Analyst Ratings for bluebird bio (BLUE) [Buys]

BLUE Rating Summary

BLUE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BLUE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $48.75 (+66.9%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/10/2021 Mizuho Securities
» Updated 3/29/2021
Difei Yang Upgrade Buy
(Neutral)
70.00
(69.00)
30.04
(29.21)
-2.76% Details
11/11/2020 Berenberg N/A New Coverage Buy
(N/A)
64.00
(N/A)
46.61
(29.21)
-37.33% Details
Like BLUE Ratings? Also take a look at BMY, EH, FUBO, JT

BLUE Ratings News